BEIJING -- Triastek, a Chinese startup using 3D technology to develop medicines, has raised about 100 million yuan ($15 million) in a Series A+ funding round.
The lead investor is Dalton Venture, while the co-investors are Shanghai Tofflon Science and Technology Chairman Zheng Xiaodong and Yunqi Partners.
